Termination of Pre-2019 Beneficiary-Specific Part D Opioid Point of Sale Claim Edits

Relevant to: All Part D Plan Sponsors

This memorandum provides instructions to Part D sponsors regarding the termination of beneficiary-specific opioid point of sale (POS) claim edits implemented prior to January 1, 2019 (“pre-2019 edits”), both within sponsors’ internal systems and in the Medicare Advantage and Prescription Drug System (MARx). Affected sponsors should make the necessary updates described in this memorandum no later than November 10, 2022.

Click here to download the full guidance as a PDF.